PEN:NYSE
Penumbra Inc
$320.91
arrow_upward
+0.05%(+0.16) 1D
$320.91
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 13, 4:00:02 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEN...
Open
$322.00
High
$322.00
Low
$320.63
Mkt. cap
12.65B
Avg. vol.
375.41K
Volume
237.60K
P/E ratio
80.79
52-wk high
$362.41
52-wk low
$274.55
EPS
$3.97
Beta
0.71
Shares outstanding
39.41M
No. of employees
5K
Open
$322.00
High
$322.00
Low
$320.63
Mkt. cap
12.65B
Avg. vol.
375.41K
Volume
237.60K
P/E ratio
80.79
52-wk high
$362.41
52-wk low
$274.55
EPS
$3.97
Beta
0.71
Shares outstanding
39.41M
No. of employees
5K
News stories
From web sources and news partners
Howl.Link
·
6 hours ago
Weekly Market Outlook – Not A Decisive Reversal Effort - TalkMarkets
صحيفة مال
·
12 hours ago
Nasdaq Records Best Weekly Performance Since August
The Motley Fool
·
7 hours ago
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
Traders Union
·
7 hours ago
Tom McClellan: NYSE Composite Index better comparison for A-D Line than S&P 500
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
About Penumbra Inc
CEOAdam Elsesser
Employees4.7K
Founded2004
Headquarters-
SectorHealth Care
IndustryMedical device
Websitepenumbrainc.com